- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fingolimod 1.25 mg
Total 11324 results
-
Hansa Biopharma ABUniversity College London HospitalsTerminatedPurpura, Thrombotic ThrombocytopenicUnited Kingdom
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Dysfunction | Female Sexual Arousal Disorder
-
Institute of Medical Biology, Chinese Academy of...Hebei Provincial Center for Diseases Control and PreventionCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Woman's Health University Hospital, EgyptCompletedHealth EducationEgypt
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedGlioblastoma | Anaplastic AstrocytomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsWithdrawnStroke | InflammationChina
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Massachusetts General HospitalALS Therapy Development InstituteCompleted
-
ShireTakeda Development Center Americas, Inc.No longer availableAngioedema | Hereditary Angioedema (HAE)United States, Canada, Germany, Hungary, Spain
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Australia, Canada, Mexico, Argentina, Puerto Rico, Chile
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisUnited States
-
Hamilton Health Sciences CorporationUniversity Health Network, Toronto; Dartmouth-Hitchcock Medical Center; Ottawa... and other collaboratorsTerminated
-
Idera Pharmaceuticals, Inc.CompletedWaldenstrom's Macroglobulinemia
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Hikma Pharmaceuticals LLCActive, not recruitingRelapsing-Remitting Multiple SclerosisEgypt
-
The Affiliated Hospital of Xuzhou Medical UniversityUnknown
-
McGill UniversityNovartisCompletedMultiple Sclerosis-Relapsing-RemittingCanada
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
Merck Sharp & Dohme LLCTerminatedLung Diseases | Pulmonary Disease, Chronic Obstructive
-
General Hospital of Shenyang Military RegionRecruiting
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsRecruitingStroke | InflammationChina
-
Boehringer IngelheimCompleted
-
Novartis PharmaceuticalsCompletedSTudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) (START)Multiple SclerosisGermany
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedChronic Inflammatory Demyelinating PolyradiculoneuropathySpain, United States, Belgium, Germany, Italy, Israel, Australia, France, United Kingdom, Netherlands, Czechia, Japan, Canada, Greece, Poland
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Drugs for Neglected DiseasesCompleted
-
Cubist Pharmaceuticals LLCCompleted
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
BioLineRx, Ltd.Active, not recruitingMultiple MyelomaUnited States, Spain, Hungary, Germany, Italy
-
RemeGen Co., Ltd.Completed
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Genentech, Inc.; Regeneron PharmaceuticalsCompletedDiabetic Macular EdemaUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsWithdrawn
-
The Methodist Hospital Research InstituteEnrolling by invitationKidney Failure, Chronic | Kidney Transplant Rejection | Graft Rejection | Kidney Transplant; Complications | Kidney Transplant Failure | Kidney Transplant Failure and Rejection | Interstitial FibrosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple Sclerosis (RMS)China
-
Teva Pharmaceuticals USACompleted
-
Franklin Health ResearchArtemis International; IPRONARecruitingCOVID-19 | Flu | Cold | Upper Respiratory Tract Infection | Flu Like IllnessUnited States
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMigraine DisordersJapan
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Teva Pharmaceuticals USACompleted
-
Sunovion Respiratory Development Inc.Completed